Stay updated on Pembrolizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no study details or outcomes appear to be affected.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.2 was added, and the funding-status notice (and Revision: v3.4.1) were removed. These are administrative site updates and do not affect the trial details or eligibility information presented on the page.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a system-wide funding lapse notice and updated the site revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check68 days agoChange DetectedShow glossary is now available, and the QC update label text was adjusted. The site revision string was updated from v3.3.4 to v3.4.0 with minor capitalization changes.SummaryDifference0.2%

- Check82 days agoChange DetectedThe page shows a minor site version update: Revision v3.3.4 was added and Revision v3.3.3 was removed, with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.